Lifecore Biomedical (LFCR) Stock: Buy, Sell, or Hold?
LFCR - Lifecore Biomedical, Inc. Common Stock
$6.54
0.01 (0.15%)
▲
5d:
+55.71%
30d:
+37.97%
90d:
+29.5%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Get Alerted When LFCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: LFCR is 22.7% above its trading range ($5.33). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: LFCR is 22.7% above its trading range ($5.33). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: LFCR is currently trading at $6.54, which is considered extended relative to its 30-day fair value range of $3.92 to $5.33.
Technical Outlook: Technically, LFCR is showing sideways momentum. The price is approaching resistance at $6.65. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: LFCR scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LFCR is showing sideways momentum. The price is approaching resistance at $6.65. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: LFCR scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.92 -
$5.33
Company Quality Score
34/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
10.5%
All Signals
- BEARISH: Price significantly overextended (+22.7% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($6.28)
- WARNING: Composite score 34/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.92 -
$5.33
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.12
Resistance Level
$6.65
Current Trend
Sideways
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-12.00
Wall Street Target
$6.28
(-4.0%)
Revenue Growth (YoY)
-3.8%
Profit Margin
-23.8%
Share & Embed Analysis
Last updated: October 03, 2026 2:35 AM ET
Data refreshes hourly during market hours. Next update: 3:35 AM
Data refreshes hourly during market hours. Next update: 3:35 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LFCR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$208 | 62 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$96 | 58 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$108 | 56 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 67 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 47 HOLD |
